Comprehensive Psychiatry
Volume 53, Issue 2 , Pages 117-124 , February 2012

Overcoming the problem of diagnostic heterogeneity in applying measurement-based care in clinical practice: the concept of psychiatric vital signs

References 

  1. Trivedi M, Rush A, Wisniewski S, Nierenberg A, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in Star⁎D implications for clinical practice. Am J Psychiatry. 2006;163:28–40
  2. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007;88S:S61–S71
  3. Gilbody SM, House AO, Sheldon TA. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry. 2002;180:101–103
  4. Zimmerman M, McGlinchey JB. Why don't psychiatrists use scales to measure outcome when treating depressed patients?. J Clin Psychiatry. 2008;69:1916–1919
  5. US Department of Health and Human Services . In: Center for Medicare and Medicaid  editors. Physician quality reporting initiative. 2008;p. 110–275
  6. Guy W. ECDEU assessment manual for psychopharmacology. Rockville, MD: National Institute of Mental Health; 1976;
  7. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, D. C.: American Psychiatric Association; 1994;
  8. Rush AJ, First MB, Blacker D. Handbook of psychiatric measures. 2nd ed. Washington: American Psychiatric Publishing, Inc; 2008;
  9. Zimmerman M, Mattia JI. Psychiatric diagnosis in clinical practice: is comorbidity being missed?. Compr Psychiatry. 1999;40:182–191
  10. Zimmerman M, Mattia JI. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatr Serv. 2000;51:1299–1304
  11. Zimmerman M. Integrating the assessment methods of researchers in routine clinical practice: the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project. In:  First M editors. Standardized evaluation in clinical practice. Vol. 22:Washington, DC: American Psychiatric Publishing, Inc; 2003;p. 29–74
  12. Posternak MA, Zimmerman M, Solomon DA. Integrating outcomes research into clinical practice: a pilot study. Psychiatr Serv. 2002;53:335–336
  13. Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice. Am J Psychiatry. 2002;159:469–473
  14. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire (PDSQ). Arch Gen Psychiatry. 2001;58:787–794
  15. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders—patient edition (SCID-i/p, version 2.0). New York, Biometrics Research Department, New York State Psychiatric Institute, 1995.
  16. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry. 1978;35:837–844
  17. Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, et al. Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. Am J Drug Alcohol Abuse. 2004;30:749–764
  18. Odlaug BL, Grant JE. Trichotillomania and pathologic skin picking: clinical comparison with an examination of comorbidity. Ann Clin Psychiatry. 2008;20:57–63
  19. Javaras KN, Pope HG, Lalonde JK, Roberts JL, Nillni YI, Laird NM, et al. Co-occurrence of binge eating disorder with psychiatric and medical disorders. J Clin Psychiatry. 2008;69:266–273
  20. Klassen LJ, Katzman MA, Chokka P. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord. 2010;124:1–8
  21. Bottlender R, Strauss A, Moller HJ. Prevalence and background factors of depression in first admitted schizophrenic patients. Acta Psychiatr Scand. 2000;101:153–160
  22. Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. Depression in first-episode schizophrenia. Am J Psychiatry. 1993;150:1643–1648
  23. Sarasalo E, Bergman B, Toth J. Personality traits and psychiatric and somatic morbidity among kleptomaniacs. Acta Psychiatr Scand. 1996;94:358–364
  24. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry. 1996;57(Suppl 8):42–47discussion 48-49
  25. Petry N, Stinson F, Grant B. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2005;66:564–574
  26. Kessler RC, Coccaro EF, Fava M, Jaeger S, Jin R, Walters E. The prevalence and correlates of DSM-IV intermittent explosive disorder in the national comorbidity survey replication. Arch Gen Psychiatry. 2006;63:669–678
  27. Zimmerman M, McGlinchey JB, Chelminski I, Young D. Diagnostic co-morbidity in 2300 psychiatric out-patients presenting for treatment evaluated with a semi-structured diagnostic interview. Psychol Med. 2008;38:199–210
  28. Zimmerman M, Chelminski I, Young D. Prevalence and diagnostic correlates of DSM-IV pathological gambling in psychiatric outpatients. J Gambl Stud. 2006;22:255–262
  29. Phillips KA, Menard W, Fay C, Weisberg R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46:317–325
  30. Blinder BJ, Cumella EJ, Sanathara VA. Psychiatric comorbidities of female inpatients with eating disorders. Psychosom Med. 2006;68:454–462
  31. Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, et al. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first multicentre study in Germany. Alcohol Alcohol. 2001;36:219–223
  32. Agosti V, Nunes E, Levin F. Rates of psychiatric comorbidity among U.S. Residents with lifetime cannabis dependence. Am J Drug Alcohol Abuse. 2002;28:643–652
  33. Conway KP, Compton W, Stinson FS, Grant BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry. 2006;67:247–257
  34. Zimmerman M, McGlinchey JB, Chelminski I. An inadequate community standard of care: lack of measurement of outcome when treating depression in clinical practice. Prim Psychiatry. 2008;15:67–75
  35. Zimmerman M, Chelminski I, McGlinchey JB, Posternak MA. A clinically useful depression outcome scale. Compr Psychiatry. 2008;49:131–140
  36. Zimmerman M, Chelminski I, Young D, Dalrymple KL. A clinically useful anxiety outcome scale. J Clin Psychiatry. 2010;71:534–542
  37. Zimmerman M, McGlinchey J. Depressed patients' acceptability of the use of self-administered scales to measure outcome in clinical practice. Ann Clin Psychiatry. 2008;20:125–129
  38. Zimmerman M, Martinez JH. Web-based assessment of depression in patients treated in clinical practice: reliability, validity and patient acceptance. J Clin Psychiatry in press.

PII: S0010-440X(11)00032-0

doi: 10.1016/j.comppsych.2011.03.004

Comprehensive Psychiatry
Volume 53, Issue 2 , Pages 117-124 , February 2012

Article Tools